
This announcement contains inside information for the purposes of Article 7 of the
("
Interim Results for the six-month period to
Background and highlights
·
· The Snorkel investment is valued at
· On
· The Company's loss in H1 2025 increased to
· As at
Overview of investments
As announced on
The Company continues to focus on other matters relating to the US Proceedings, which are continuing, with the trial beginning in
Further updates will be provided to Shareholders as and when appropriate.
For further information:
James Joyce / Andrew de Andrade 0203 829 5000
STATEMENT OF COMPREHENSIVE INCOME |
|||||||||||||||
FOR THE SIX MONTHS ENDING |
|
|
|||||||||||||
|
|
|
Six months to |
Six months to |
Year to 31 Dec 24 (audited) |
|
|||||||||
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||||
Revenue |
|
|
- |
- |
- |
|
|||||||||
Staff costs |
|
|
(101) |
(79) |
(159) |
|
|||||||||
Other operating income |
|
|
3 |
11 |
16 |
|
|||||||||
Other operating expenses |
|
|
(491) |
(116) |
(260) |
|
|||||||||
Loss from operations |
|
|
(589) |
(184) |
(403) |
|
|||||||||
Finance expense |
|
|
- |
- |
- |
|
|||||||||
Finance income |
|
|
49 |
87 |
132 |
|
|||||||||
Loss before tax |
|
|
(540) |
(97) |
(271) |
|
|||||||||
Taxation |
|
|
- |
- |
- |
|
|||||||||
Loss & total comprehensive income for the period attributable to equity shareholders |
(540) |
(97) |
(271) |
|
|||||||||||
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||||
Loss per share |
|
|
|
|
|
|
|||||||||
Basic and diluted (p) |
|
|
(0.33) |
(0.06) |
(0.17) |
|
|||||||||
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||||
BALANCE SHEET |
|||||||||||
AS AT |
|
|
|||||||||
|
|
|
(unaudited) |
(unaudited) |
(audited) |
|
|||||
|
|
|
|
|
|
|
|||||
Non-current assets |
|
|
|
|
|
|
|||||
Non-current Investments |
|
|
19,100 |
19,100 |
19,100 |
|
|||||
|
|
|
19,100 |
19,100 |
19,100 |
|
|||||
Current assets |
|
|
|
|
|
|
|||||
Trade and other receivables |
|
|
30 |
79 |
44 |
|
|||||
Cash and cash equivalents |
|
|
430 |
3,333 |
2,909 |
|
|||||
Short-term deposits |
|
|
2,350 |
- |
300 |
|
|||||
|
|
|
2,810 |
3,412 |
3,253 |
|
|||||
|
|
|
|
|
|
|
|||||
Total assets |
|
|
21,910 |
22,512 |
22,353 |
|
|||||
|
|
|
|
|
|
|
|||||
Current liabilities |
|
|
|
|
|
|
|||||
Trade and other payables |
|
|
162 |
50 |
65 |
|
|||||
|
|
|
162 |
50 |
65 |
|
|||||
|
|
|
|
|
|
|
|||||
Total liabilities |
|
|
162 |
50 |
65 |
|
|||||
|
|
|
|
|
|
|
|||||
Equity |
|
|
|
|
|
|
|||||
Share capital |
|
|
8,145 |
8,145 |
8,145 |
|
|||||
Share premium |
|
|
17,336 |
17,336 |
17,336 |
|
|||||
Special reserve |
|
|
66,837 |
66,837 |
66,837 |
|
|||||
Merger reserve |
|
|
1,534 |
1,534 |
1,534 |
|
|||||
Retained earnings |
|
|
(72,104) |
(71,390) |
(71,564) |
|
|||||
Total equity |
|
|
21,748 |
22,462 |
22,288 |
|
|||||
|
|
|
|
|
|
|
|||||
Total equity and total liabilities |
|
|
21,910 |
22,512 |
22,353 |
|
|||||
|
|
|
|
|
|
|
|||||
|
|||||||||||
STATEMENT OF CHANGES IN EQUITY |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
CASH FLOW STATEMENT |
|||||||
FOR THE SIX MONTHS ENDING |
|
|
|||||
|
|
Six months to |
Six months to |
Year to 31 Dec 24 (audited) |
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
(Loss)/profit before tax |
|
(540) |
(97) |
(271) |
|
||
Adjustment for: |
|
|
|
|
|
||
Finance expense |
|
- |
- |
- |
|
||
Finance income |
|
(49) |
(87) |
(132) |
|
||
Changes in operating assets and liabilities / working capital: |
|
|
|
|
|
||
(Increase)/decrease in receivables |
|
14 |
(21) |
14 |
|
||
Increase/(decrease) in payables |
|
97 |
(22) |
(7) |
|
||
Net Cash used in operations |
|
(478) |
(227) |
(396) |
|
||
|
|
|
|
|
|
||
Cash flow from Investing Activities |
|
|
|
|
|
||
Interest received |
|
49 |
87 |
132 |
|
||
Short-term deposits |
|
(2,050) |
- |
(300) |
|
||
Net Cash used in investing activities |
|
(2,001) |
87 |
(168) |
|
||
|
|
|
|
|
|
||
Net decrease in cash and cash equivalents |
|
(2,479) |
(140) |
(564) |
|
||
Cash and cash equivalents at the start of period |
|
2,909 |
3,473 |
3,473 |
|
||
Cash and cash equivalents at the end of the period |
|
430 |
3,333 |
2,909 |
|
||
1 Basis of preparation The Interim Report of the Company for the six months ended
The half year report does not constitute financial statements as defined in Section 434 of the Companies Act 2006 and does not include all of the information and disclosures required for full annual statements. It should be read in conjunction with the annual report and financial statements for the year ended
2 Accounting Policies Impact of accounting standards to be applied in future periods There are a number of standards and interpretations which have been issued by the
|
||||||||||||||
|
3 Loss per share |
|
||||||||||||
The calculation of the basic and diluted loss per share is based on the following data: |
|
|||||||||||||
|
|
Six months |
Six months |
Year to |
|
|||||||||
|
|
to |
to |
|
|
|||||||||
|
|
|
|
|
|
|||||||||
Number of shares |
|
000's |
000's |
000's |
|
|||||||||
Weighted average number of ordinary shares for the purposes of basic earnings per share |
|
162,907 |
162,907 |
162,907 |
|
|||||||||
|
|
|||||||||||||
|
|
|||||||||||||
Loss From operations |
|
|
|
|
|
|||||||||
Loss for the purposes of basic earnings per share being net profit attributable to owners of the parent |
|
(540) |
(97) |
(271) |
||||||||||
|
|
|
|
|
||||||||||
Loss per share from operations |
|
|
|
|
|
|||||||||
Basic and diluted (p) |
|
(0.33) |
(0.06) |
(0.17) |
|
|||||||||
|
||||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the